LU Bio has decided to close the portfolio company Auril
LU Bio has together with the inventors decided that the Auril project shall return from development phase back to research phase. There is a need to gain further insight and understanding of the temperature regulating mechanisms to be able to prepare for a clinical trial application. LU Bio has transferred all the IPR to the inventors and has closed the portfolio company.